Remote And Hybrid Work In The Pharma Industry Statistics 2026

Hybrid work is now a standard operating model in life sciences. In 2024, 73% of life sciences and healthcare organizations reported using hybrid models for at least some roles. In the same sector, virtual meetings rose 1.6x per week, while 23% of employees reported higher stress under hybrid work.

Key Takeaways

43% of pharma workers were able to work remotely at least some of the time in the United States (2022 survey)
34% of U.S. employees who could work from home reported they did so at least 5 days per week (2022)
Hybrid work arrangements were offered by 65% of companies surveyed in 2023, with higher adoption in knowledge-intensive industries including professional services (industry-wide survey)
3.2x increase in video conferencing usage since pre-pandemic peak in 2019 among organizations that implemented remote/hybrid work (global collaboration metrics)
67% of knowledge workers reported their organizations use cloud-based collaboration tools (2022 survey)
89% of organizations reported using some form of video conferencing for remote/hybrid work (2021 survey)
24% of U.S. workers reported they were working from home or remotely because of COVID-19 in 2021 (share of workers), indicating large-scale remote work uptake during the pandemic era.
48% of U.S. knowledge workers reported they would like to work remotely at least 2–3 days per week (share of knowledge workers).
73% of life sciences and healthcare organizations reported using a hybrid work model for at least some roles in 2024 (share of organizations).
1.6x increase in the number of virtual meetings per week reported by life sciences professionals operating in hybrid settings (ratio vs pre-hybrid baseline).
38% of life sciences respondents reported that they redesigned workflows to support hybrid delivery of work (share of respondents).
85% of organizations reported using video conferencing for remote or hybrid meetings in 2023 (share of organizations).
52% of organizations reported implementing new collaboration security controls specifically for hybrid work in 2022 (share of organizations).
39% of organizations reported using digital identity and access management solutions to manage hybrid workforce access in 2023 (share of organizations).
54% of organizations reported increased use of endpoint detection and response (EDR) to secure hybrid workforces in 2022 (share of organizations).

In pharma, hybrid work is widespread and desired, but it boosts meetings and security needs.

01 · Category

Workforce Availability12 stats

43% of pharma workers were able to work remotely at least some of the time in the United States (2022 survey)

34% of U.S. employees who could work from home reported they did so at least 5 days per week (2022)

Hybrid work arrangements were offered by 65% of companies surveyed in 2023, with higher adoption in knowledge-intensive industries including professional services (industry-wide survey)

1.7 days per week was the median time employees spent in the office in hybrid arrangements reported by survey respondents in 2022 (Workplace Analytics report)

62% of employees said they would like to work from home at least 2–3 days per week (global survey, 2021)

72% of life sciences organizations reported using hybrid work models for at least some roles (2022 survey)

30% of pharma roles were estimated to be fully remote-capable based on work-task characteristics (2020–2021 modeling study on work activities)

37% of respondents in an industry survey reported they had hybrid arrangements with flexible office days (2022)

1.4 million U.S. workers in life sciences and adjacent sectors were working remotely at least some time in 2021 (BLS job and remote-work estimates)

66% of employees said they would remain with their employer longer if remote/hybrid flexibility were available (2022 employer survey)

33% of life sciences organizations reported reducing office space due to hybrid adoption (2022)

57% of managers in hybrid organizations reported they held more meetings than pre-pandemic (2021)

Interpretation

Workforce Availability Interpretation

In the pharma and life sciences workforce, remote and hybrid access is already common, with 43% of workers able to work remotely at least some of the time in the US and 72% of life sciences organizations using hybrid models for at least some roles, suggesting that workforce availability is increasingly flexible for many roles.

02 · Category

Industry Trends16 stats

3.2x increase in video conferencing usage since pre-pandemic peak in 2019 among organizations that implemented remote/hybrid work (global collaboration metrics)

67% of knowledge workers reported their organizations use cloud-based collaboration tools (2022 survey)

89% of organizations reported using some form of video conferencing for remote/hybrid work (2021 survey)

52% of organizations reported implementing new security controls specifically to support remote/hybrid work (2022)

31% of employers reported adopting more than one collaboration platform to support hybrid teams (2022)

24% of organizations reported migrating to cloud productivity suites for remote work in 2021 (survey)

19% of organizations reported security incidents involving remote endpoints in the last 12 months (2023)

42% of companies reported that remote/hybrid work increased help-desk tickets (2021)

1.9x increase in cloud application usage during remote work periods (2020–2021)

28% of organizations reported staff turnover intentions were affected by hybrid work flexibility (2022)

23% of employees reported increased stress under hybrid work compared to pre-pandemic (2021)

2.7x more phishing attempts targeting remote workers in 2020 vs prior baseline (industry threat report)

35% of hybrid workers reported that meeting overload harms productivity (2022 survey)

31% of employees reported that hybrid work required them to manage more “coordination overhead” than expected (2022)

39% of organizations report they track collaboration metrics (e.g., meeting counts, response times) to manage hybrid teams (2023 survey)

29% of trial sites reported using telemedicine for participant assessments during remote/hybrid trial operations (2022 study)

Interpretation

Industry Trends Interpretation

The pharma industry is doubling down on Industry Trends in remote and hybrid work as video conferencing usage has risen 3.2x since the 2019 peak and nearly nine in ten organizations use video conferencing for remote and hybrid collaboration.

03 · Category

Remote Work Prevalence2 stats

24% of U.S. workers reported they were working from home or remotely because of COVID-19 in 2021 (share of workers), indicating large-scale remote work uptake during the pandemic era.

48% of U.S. knowledge workers reported they would like to work remotely at least 2–3 days per week (share of knowledge workers).

Interpretation

Remote Work Prevalence Interpretation

In the Remote Work Prevalence category, the contrast between 24% of U.S. workers working from home in 2021 due to COVID-19 and 48% of U.S. knowledge workers wanting to work remotely at least 2–3 days per week shows a strong and lasting demand for more hybrid-friendly arrangements in pharma and beyond.

04 · Category

Hybrid Strategy In Pharma3 stats

73% of life sciences and healthcare organizations reported using a hybrid work model for at least some roles in 2024 (share of organizations).

1.6x increase in the number of virtual meetings per week reported by life sciences professionals operating in hybrid settings (ratio vs pre-hybrid baseline).

38% of life sciences respondents reported that they redesigned workflows to support hybrid delivery of work (share of respondents).

Interpretation

Hybrid Strategy In Pharma Interpretation

In the hybrid strategy in pharma, 73% of life sciences and healthcare organizations are already using hybrid work for at least some roles in 2024, and this shift is showing up in practice with a 1.6x rise in virtual meetings and 38% of respondents redesigning workflows to make hybrid delivery work.

Remote And Hybrid Work In IndustryRemote And Hybrid Work In The Big Data Industry Statistics

05 · Category

Collaboration & Tooling3 stats

85% of organizations reported using video conferencing for remote or hybrid meetings in 2023 (share of organizations).

52% of organizations reported implementing new collaboration security controls specifically for hybrid work in 2022 (share of organizations).

39% of organizations reported using digital identity and access management solutions to manage hybrid workforce access in 2023 (share of organizations).

Interpretation

Collaboration & Tooling Interpretation

In the pharma industry’s Collaboration and Tooling landscape, adoption is clearly technology driven, with 85% of organizations using video conferencing for remote or hybrid meetings in 2023, while 52% added hybrid-focused collaboration security controls in 2022 and 39% rely on digital identity and access management to manage hybrid workforce access in 2023.

06 · Category

Compliance & Security1 stats

54% of organizations reported increased use of endpoint detection and response (EDR) to secure hybrid workforces in 2022 (share of organizations).

Interpretation

Compliance & Security Interpretation

In 2022, 54% of pharma organizations increased their use of endpoint detection and response to better secure hybrid workforces, underscoring a strong compliance and security push toward stronger endpoint-level protection.

07 · Category

Business Outcomes4 stats

27% of employees reported that hybrid work increased coordination overhead that reduced time for core tasks (share of employees).

22% of respondents reported higher employee turnover risk associated with hybrid work arrangements (share of respondents).

1.3x increase in collaboration volume reported by teams using hybrid work in 2022 (ratio vs prior period).

31% of organizations reported reducing office space footprint as a result of hybrid work adoption (share of organizations).

Interpretation

Business Outcomes Interpretation

From a business outcomes perspective, hybrid and remote work is driving measurable collaboration gains and cost savings, with a 1.3x rise in collaboration volume and 31% of organizations cutting office space footprint, while also creating real operational and people risks like 27% reporting coordination overhead that reduces time for core tasks and 22% flagging higher turnover risk.

report visual · Breakdown

How often and how much—remote & hybrid uptake in pharma (US + life sciences)

A large share of pharma/life-sciences roles can operate with remote or hybrid work, and many employees want flexibility—while organizations report adoption and operational shifts.

43%

43% of pharma workers were able to work remotely at least some of the time in the United States (2022 survey)

57%

57% of managers in hybrid organizations reported they held more meetings than pre-pandemic (2021)

source-verifiedbls.gov · microsoft.com2022

Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA

Catherine Wu. (2026, February 13). Remote And Hybrid Work In The Pharma Industry Statistics. Gitnux. https://gitnux.org/remote-and-hybrid-work-in-the-pharma-industry-statistics

MLA

Catherine Wu. "Remote And Hybrid Work In The Pharma Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/remote-and-hybrid-work-in-the-pharma-industry-statistics.

Chicago

Catherine Wu. 2026. "Remote And Hybrid Work In The Pharma Industry Statistics." Gitnux. https://gitnux.org/remote-and-hybrid-work-in-the-pharma-industry-statistics.